Clinical trial
E7389 Versus Treatment of Physician's Choice in Patients With Locally Recurrent…
NCT00388726 · Eisai Inc., Industry · Completed
Key facts
| NCT number | NCT00388726 |
|---|---|
| Title | E7389 Versus Treatment of Physician's Choice in Patients With Locally Recurrent or Metastatic Breast Cancer |
| Official title | The "EMBRACE" Trial: Eisai Metastatic Breast Cancer Study Assessing Physician's Choice Versus E7389. A Phase III Open-Label, Randomized, Parallel, Two-arm, Multi-center Study of E7389 Versus "Treatment of Physician's Choice" in Patients With Locally Recurrent, Metastatic Breast Cancer, Previously… |
| Lead sponsor | Eisai Inc., Industry |
| Collaborators | Eisai Limited Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Drug |
| Interventions | E7389, Physician's Choice |
| Enrollment | 762 |
| Start date | Nov 1, 2006 |
| Primary completion | May 1, 2009 |
| Completion | Jun 1, 2013 |
| First posted | Oct 17, 2006 |
| Last update posted | Jan 7, 2020 |
| Countries | Argentina, Australia, Austria, Belgium, Brazil, Canada, Croatia, Czechia, France, Hungary, Italy, Poland and 5 more |
At a glance
- 100–999 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: